Patents

US 9108966 B2: Beta-lactamase inhibitors

Granted
2015-08-18
Filed
2014-03-17 application 14216476
Type
Utility · 3 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Aryl substituted diazabicyclooctanes (DBO) compounds that inhibit β-lactamases of class A, class C or class D and potentiate β-lactam antibiotics are disclosed. In particular, this disclosure provides DBO compounds that, when used in the disclosed Synergy MIC Assay with a β-lactam antibiotic at a fixed concentration have an MIC of 8 μg/mL or less against one or more isogenic β-lactamase expressing bacterial strains.

Source: PVGPATDIS, file of 2026-04-10 (ipg150818.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Cubist Pharmaceuticals LLC 29 patentsForeign company or organizationLexington, MACUBIST PHARMACEUTICALS INC SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationallyPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Yu Gui GuActon, MA16PVGPATDIS, file of 2026-04-10
Yong HeBedford, MA76PVGPATDIS, file of 2026-04-10
Ning YinLexington, MA16PVGPATDIS, file of 2026-04-10
Dylan C. AlexanderWatertown, MA9PVGPATDIS, file of 2026-04-10
Jason CROSSActon, MA36PVGPATDIS, file of 2026-04-10
Robert BuschWakefield, MA3PVGPATDIS, file of 2026-04-10
Roland E. DolleAshland, MA24PVGPATDIS, file of 2026-04-10
Chester A. Metcalf, IIINeedham, MA23PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D471/08PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K31/439PVGPATDIS, file of 2026-04-10
Y02ATechnologies for adaptation to climate changeY02A50/30PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2015-08-06Assignment
Nunc pro tunc assignment
CUBIST PHARMACEUTICALS LLC signed 2015-08-05MERCK SHARP & DOHME CORP. RAHWAY, NJ36268/626ECORSEXC, file of 2026-09-25
2015-08-05Name change
Change of name
CUBIST PHARMACEUTICALS, INC. signed 2015-06-29CUBIST PHARMACEUTICALS LLC KENILWORTH, NJ36283/189PASDL, file of 2026-10-15
2015-02-24Assignment
Assignment of assignor's interest
ALEXANDER, DYLAN C. signed 2013-04-24
BUSCH, ROBERT signed 2013-04-24
CROSS, JASON B. signed 2013-04-24
DOLLE, ROLAND E. signed 2013-04-24
GU, YU GUI signed 2013-04-24
HE, YONG signed 2013-04-24
YIN, NING signed 2013-04-24
METCALF, CHESTER A., III signed 2013-04-26
CUBIST PHARMACEUTICALS, INC. LEXINGTON, MA35015/831ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.